Reproductive Endocrinology Ovarian Hormones

Progesterone administration by nasal spray

Cicinelli E, Ragno G, Cagnazzo I, Fanelli F, Vetuschi C, Schonauer S

Published July 1991 Fertility and Sterility, 56(1), 139-141
DOI 10.1016/s0015-0282(16)54433-1 PMID 2065793

RRM Academy Synopsis

Nasal progesterone spray raised blood levels in menopausal women

In a 1991 absorption study of 10 healthy menopausal women, blood progesterone peaked 60 minutes after the nasal spray and stayed high until 6 hours. The authors judged the spray acceptable and probably clinically safe.

Key Findings

  • Ten healthy menopausal women, aged 52 to 61 years (mean, 56.4 years), each received the progesterone spray once, and blood samples were drawn up to 720 minutes afterward.
  • Blood progesterone reached its maximum 60 minutes after administration, and a secondary peak followed at 240 minutes.
  • Progesterone levels the authors call physiological lasted until 360 minutes and returned to baseline values after 12 hours.
  • Variability in circulating progesterone did not exceed 34% until 720 minutes in any patient.
  • Each of the 10 women reported a slightly unpleasant taste within a few minutes, and nasal examination showed no evidence of irritation in any woman.

Interpretation

The study is a single-administration absorption study. One group of 10 healthy menopausal women received the same spray, and blood progesterone was measured for 12 hours. The measurements describe how the hormone enters the blood in women of that age. The authors note that the lack of estrogen in menopause modifies the absorption capacity of the nasal lining and warrants further study. They report that the cause of the second peak is unknown. The study recorded blood progesterone, baseline estradiol and the appearance of the nasal lining.

RRM Context

Progesterone is the body's own hormone. Progestins are synthetic alterations of it, and RRM keeps the two terms separate. This paper studies unmodified progesterone given through the nose. The authors call that a potentially useful approach that avoids first-pass metabolism in the liver. The introduction reviews oral, rectal, vaginal and sublingual routes and reports variable or modest blood levels for them.

Abstract

The bioavailability and the clinical usefulness of the P administered by nasal spray were investigated. Ten healthy menopausal women received an IN spray administration (4 doses of an oleic P solution 20 mg/mL, corresponding to nearly 11.2 mg of P) and the circulating P levels were calculated. Sixty minutes after administration, the maximum concentration (CMax, 3.75 +/- 0.214 ng/mL) was reached. High P levels (greater than 2 ng/mL) lasted until 360 minutes, and the AUC 0 to 720 was 1,481.6 +/- 343 ng.h/mL. Progesterone administration by spray formulation has proven to be effective in reaching therapeutic levels and to be acceptable to patients and, probably, clinically safe.

Topics

By this author

Related research

Reproductive Endocrinology › Ovarian Hormones › Progesterone · Therapeutics › Hormonal Agents › Progesterone and Progestins · Perimenopause and Menopause › Hormone Therapy › Bioidentical Hormones
Ettore Cicinelli, Gaetano Ragno, Iginio Cagnazzo, Francesco Fanelli, Claudio Vetuschi, Sergio Schonauer
E Cicinelli, G Ragno, I Cagnazzo, F Fanelli, C Vetuschi, S Schonauer
PMID 2065793 2065793 DOI 10.1016/s0015-0282(16)54433-1 10.1016/s0015-0282(16)54433-1 Cicinelli et al. 1991, Cicinelli 1991